E-LIB Suche - Ergebnisse für: Britto, Paula

1

Pharmacokinetics and Safety of 3 Months of Weekly Rifapenti..:

Mathad, Jyoti S ; Savic, Rada ; Britto, Paula...
Clinical Infectious Diseases. 74 (2021) 9 - p. 1604-1613 , 2021

Link: https://doi.org/10.1093/..

2

Effects of water‐ and land‐based exercises on quality of li..:

Britto, André ; Rodrigues, Vandilson ; dos Santos, Alcione M....
Musculoskeletal Care. 18 (2020) 4 - p. 459-466 , 2020

Link: https://doi.org/10.1002/..

3

Adverse Pregnancy Outcomes Among Women Who Conceive on Anti..:

Hoffman, Risa M ; Brummel, Sean S ; Britto, Paula...
Clinical Infectious Diseases. 68 (2018) 2 - p. 273-279 , 2018

Link: https://doi.org/10.1093/..

4

Randomized trial of stopping or continuing ART among postpa..:

Currier, Judith S. ; Britto, Paula ; Hoffman, Risa M....
PLOS ONE. 12 (2017) 5 - p. e0176009 , 2017

Link: https://doi.org/10.1371/..

5

Pharmacokinetics of Darunavir/Ritonavir With Etravirine Bot..:

Cressey, Tim R. ; Yogev, Ram ; Wiznia, Andrew...
Journal of the Pediatric Infectious Diseases Society. , 2016

Link: https://doi.org/10.1093/..

6

Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and..:

Larson, Kajal B. ; Cressey, Tim R. ; Yogev, Ram...
Journal of the Pediatric Infectious Diseases Society. 5 (2015) 2 - p. 131-137 , 2015

Link: https://doi.org/10.1093/..

7

A Comparison of 3 Regimens to Prevent Nevirapine Resistance..:

Van Dyke, Russell B. ; Ngo-Giang-Huong, Nicole ; Shapiro, David E....
Clinical Infectious Diseases. 54 (2012) 2 - p. 285-293 , 2012

Link: https://www.jstor.org/st..

8

Psychological Factors, Beliefs About Medication, and Adhere..:

Garvie, Patricia A. ; Flynn, Patricia M. ; Belzer, Marvin...
Journal of Adolescent Health. 48 (2011) 6 - p. 637-640 , 2011

Link: https://doi.org/10.1016/..

9

Development of Resistance Mutations in Women Receiving Stan..:

Cunningham, Coleen K. ; Chaix, Marie‐Laure ; Rekacewicz, Claire...
The Journal of Infectious Diseases. 186 (2002) 2 - p. 181-188 , 2002

Link: https://doi.org/10.1086/..

10

Development of Resistance Mutations in Women Receiving Stan..:

Cunningham, Coleen K. ; Chaix, Marie-Laure ; Rekacewicz, Claire...
The Journal of Infectious Diseases. 186 (2002) 2 - p. 181-188 , 2002

Link: https://www.jstor.org/st..

11

Pharmacokinetics of nelfinavir in human immunodeficiency vi..:

CAPPARELLI, EDMUND V. ; SULLIVAN, JOHN L. ; MOFENSON, LYNNE...
The Pediatric Infectious Disease Journal. , 2001

Link: https://doi.org/10.1097/..

12

The effects of zidovudine in the subset of infants infected..:

McSherry, George D. ; Shapiro, David E. ; Coombs, Robert W....
The Journal of Pediatrics. 134 (1999) 6 - p. 717-724 , 1999

Link: https://doi.org/10.1016/..

13

Risk Factors for Perinatal Human Immunodeficiency Virus Tra..:

SHAPIRO, DAVID E. ; SPERLING, RHODA S. ; MANDELBROT, LAURENT..
Obstetrics & Gynecology. 94 (1999) 6 - p. 897-908 , 1999

Link: https://doi.org/10.1097/..

14

Maternal Viral Genotypic Zidovudine Resistance and Infreque..:

Eastman, P. Scott ; Shapiro, David E. ; Coombs, Robert W....
The Journal of Infectious Diseases. 177 (1998) 3 - p. 557-564 , 1998

Link: https://www.jstor.org/st..

15

Maternal Viral Genotypic Zidovudine Resistance and Infreque..:

Eastman, P. Scott ; Shapiro, David E. ; Coombs, Robert W....
The Journal of Infectious Diseases. 177 (1998) 3 - p. 557-564 , 1998

Link: https://doi.org/10.1086/..